Table 3.
A Partial List of Dry Powder Inhalers That Have Been Approved by the U.S. FDA
| Year, product name | Drug(s) | Company |
|---|---|---|
| 1940s, Aerohalor | Isoproterenol sulfate | Abbott |
| 1970, Spinhaler | Cromolyn sodium | Fisons |
| 1988, Ventolin Rotacaps | Albuterol | Glaxo |
| 1997, Flovent Diskus | Fluticasone | Glaxo Wellcome |
| 1997, Serevent Diskus | Salmeterol | Glaxo Wellcome |
| 1997, Pulmicort Turbuhaler | Budesonide | Astra Zeneca |
| 1999, Relenza Diskhaler | Zanamivir | Glaxo Wellcome |
| 2000, Advair Diskus | Fluticasone/salmeterol | GlaxoSmithKline |
| 2001, Foradil Aerolizer | Formoterol fumarate | Schering Plough/Novartis |
| 2004, Spiriva Handihaler | Tiotropium bromide | Boehringer Ingelheim |
| 2005, Asmanex Twisthaler | Mometasone furoate | Schering Plough |
| 2006, Exubera | Recombinant human insulin | Nektar/Pfizer |
| 2006, Pulmicort Flexhaler | Budesonide | Astra Zeneca |
| 2006, Foradil Certihaler | Formoterol fumarate | Schering Plough/Novartis |
| 2010, Aridol | Mannitol | Pharmaxis |
| 2011, Arcapta Neohaler | Indacaterol maleate | Novartis |
| 2013, Tobi Podhaler | Tobramycin inhalation powder | Novartis |
| 2013, Breo Ellipta | Fluticasone furoate/vilanterol | GlaxoSmithKline |
| 2014, Incruise Ellipta | Umeclidinium | GlaxoSmithKline |
| 2014, Afrezza | Human recombinant insulin | MannKind |